The momentum generated by government policies aimed at stabilizing foreign investment, combined with the rapid growth of green and artificial intelligence-driven economies, will deliver strong tailwinds for foreign companies in China this year, said foreign business executives.

With rising global economic headwinds and uncertainty over United States' trade policies, many global enterprises are opting to consolidate their presence in China, with plans to maintain or expand investment.

China's stable and business-friendly environment supported a modest rebound in foreign direct investment in March, with actual FDI inflows into the Chinese mainland increasing by 13.2 percent year-on-year, data from the Ministry of Commerce showed.

Marelli Holdings Co Ltd, a Saitama, Japan-headquartered multinational automotive parts manufacturer with more than 50 manufacturing facilities across the world, will expand its engineering team from 800 to 1,000 in China over the next three years.

"Many opportunities arise from Chinese automakers' rapid shift toward electrification and intelligence, especially in the form of software-defined vehicles, which are setting new benchmarks for speed, scale and innovation," said David Slump, the group's president and CEO.

With China and the US agreeing to de-escalate trade tensions last week, Slump said that these two countries are major markets for Marelli.

"We are closely monitoring and assessing the situation, and are committed to minimizing any impact on our operations and customers," said Slump. He added that the company is already exporting advanced products and solutions from China to other markets, including Europe, Mexico and Southeast Asia.

Also upbeat about the Chinese market, British pharmaceutical company AstraZeneca announced in March an investment of $2.5 billion to establish in Beijing its sixth global strategic R&D center, and further expand its biotech innovation partnerships and local manufacturing capabilities.

The new facility will advance early-stage research and clinical development and will be enabled by a new AI and data science laboratory.

Susan Galbraith, executive vice-president, oncology R&D, Astra-Zeneca, said that having two of its six global strategic R&D centers in China reflects the group's confidence in China's world-class biomedical innovation ecosystem and reinforces the nation's critical role in its global R&D strategy.

Ji Wenhua, a professor at the Academy of China Open Economy Studies, which is part of the University of International Business and Economics in Beijing, said that China's well-developed industrial bases, strong supply chain resilience and policy emphasis on innovation continue to make it an attractive destination for global capital.

According to China's 2025 Action Plan for Stabilizing Foreign Investment, the country will support pilot regions in effectively implementing opening-up policies related to areas such as value-added telecommunication, biotechnology and wholly foreign-owned hospitals, providing whole-journey services for foreign-invested projects in these sectors.

The action plan also supports foreign businesses to participate in China's new industrialization, with a focus on high-tech fields. Global capital has been welcomed in service sectors such as elderly care, culture and tourism, sports, healthcare, vocational education and finance.

As part of its strategy to strengthen operations in China, US express transportation service provider FedEx Corp announced in mid-May that it would enhance its international export services from Shanghai.

The cutoff times for same-day outbound shipments from Shanghai to Europe, Asia-Pacific and the Middle East, India and Africa will be further extended.

The foreign trade value of foreign-invested businesses reached 4.1 trillion yuan ($567.51 billion) in China between January and April, up 1.9 percent year-on-year, accounting for 29 percent of China's total foreign trade value, statistics from the General Administration of Customs showed.

In the meantime, Jiangsu province, a major hub for foreign-invested companies, recorded 864.25 billion yuan in foreign trade value, up 7.2 percent year-on-year, according to Nanjing Customs.